Plant milk is on the cusp of another boom as the industry courts a huge demographic it has ignored so far: children.
Using colorful bottles of oat and pea milk packed with protein and prebiotics, the category is winning over parents. At Ripple Foods, a start-up that has raised more than US$200 million, its plant-based option for kids has more calcium and vitamin D than cows’ milk.
Sales of the offering have more than doubled expectations since launching last year, and distribution is increasing by more than 10,000 locations this year, including its debut in Kroger, the largest grocery chain in
Lab-grown fish startup BlueNalu lands $60 million to build out factory By Mike Freeman, The San Diego Union-Tribune
Published: January 24, 2021, 6:08am
Share: BlueNaluCfUs signage installation at their nearly 40,000 square foot pilot production facility in San Diego. (BlueNalu)
San Diego startup BlueNalu, which is growing fish fillets in a lab directly from real fish cells, has raised $60 million in convertible debt financing to build out a pilot factory, continue to pursue regulatory approval and launch its seafood in restaurants.
The 3-year-old firm, which was featured on CNBC’s Streets of Dreams with Marcus Lemonis on Tuesday, is developing cell lines to grow up to eight species of seafood with mahi-mahi and bluefin tuna targeted as its initial products.
San Diego startup BlueNalu, which is growing fish fillets in a lab directly from real fish cells, has raised $60 million in convertible debt financing to build out a pilot factory, continue to pursue regulatory approval and launch its seafood in restaurants.
The 3-year-old firm, which was featured o
Print
San Diego startup BlueNalu, which is growing fish fillets directly from real fish cells, has raised $60 million in convertible debt financing to build out a pilot factory, continue to pursue regulatory approval and launch its seafood in restaurants.
The 3-year-old firm, which was featured on CNBC’s Streets of Dreams with Marcus Lemonis on Tuesday, is developing cell lines to grow up to eight species of seafood with mahi-mahi and bluefin tuna targeted as its initial products.
Depending on the pace of U.S. Food and Drug Administration review, BlueNalu could roll out its first cell-based mahi-mahi this year, said President and Chief Executive Lou Cooperhouse.